Skip to content

More people with HIV are achieving viral suppression in US, but about 40% remain above transmission thresholds

Heather Bradley presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

No adverse social consequences from early ART initiation in West Africa

African women in London with poor adherence feel that HIV treatment is difficult and unrelenting

Long-acting oral antiretroviral MK-8591 could represent 'paradigm shift' in HIV treatment and prophylaxis

Gene therapy snips HIV out of infected cells and makes uninfected cells resistant

ART has averted over 850,000 HIV-related opportunistic infections in low and middle income countries

Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study

Starting HIV therapy associated with improvements in liver function, especially when viral load is suppressed

Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

Erik Mogalian at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com